{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:37:36Z","timestamp":1793864256135,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1118019"],"award-info":[{"award-number":["1118019"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bioadv.2023.213388","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T03:41:02Z","timestamp":1678938062000},"page":"213388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery"],"prefix":"10.1016","volume":"149","author":[{"given":"Tianjiao","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euphemia","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence W.","family":"Chamley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioadv.2023.213388_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06502","article-title":"Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis","volume":"7","author":"Chaudhary","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.bioadv.2023.213388_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.111984","article-title":"Cholesterol-rich nanoemulsion (LDE) as a novel drug delivery system to diagnose, delineate, and treat human glioblastoma","volume":"123","author":"Tedesco","year":"2021","journal-title":"Mater Sci Eng C."},{"key":"10.1016\/j.bioadv.2023.213388_bb0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.omto.2022.02.012","article-title":"A novel TanCAR targeting IL13R\u03b12 and EphA2 for enhanced glioblastoma therapy","volume":"24","author":"Muhammad","year":"2022","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.bioadv.2023.213388_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2021.07.004","article-title":"Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: a head-to-head comparison","volume":"336","author":"Wu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2023.213388_bb0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2020.08.018","article-title":"Cancer therapy based on extracellular vesicles as drug delivery vehicles","volume":"327","author":"Cabeza","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2023.213388_bb0030","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jconrel.2021.12.024","article-title":"Emerging prospects of extracellular vesicles for brain disease theranostics","volume":"341","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0035","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioadv.2023.213388_bb0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.addr.2021.04.027","article-title":"Separation, characterization, and standardization of extracellular vesicles for drug delivery applications","volume":"174","author":"Buschmann","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioadv.2023.213388_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11095-021-02988-z","article-title":"Recent advancement and technical challenges in developing small extracellular vesicles for cancer drug delivery","volume":"38","author":"Geng","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioadv.2023.213388_bb0050","doi-asserted-by":"crossref","first-page":"113801","DOI":"10.1016\/j.addr.2021.05.011","article-title":"Extracellular vesicles as a drug delivery system: a systematic review of preclinical studies","volume":"175","author":"de Castilla","year":"2021","journal-title":"Adv Drug Deliv Rev."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213388_bb0055","doi-asserted-by":"crossref","first-page":"e12085","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"10.1016\/j.bioadv.2023.213388_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","article-title":"Cellular internalization of exosomes occurs through phagocytosis","volume":"11","author":"Feng","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.bioadv.2023.213388_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.carbpol.2018.08.141","article-title":"pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery","volume":"202","author":"Lee","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2023.213388_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108032","article-title":"Hyaluronan decoration of milk exosomes directs tumor-specific delivery of doxorubicin","volume":"493","author":"Li","year":"2020","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioadv.2023.213388_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2020.11.062","article-title":"Engineering approaches for effective therapeutic applications based on extracellular vesicles","volume":"330","author":"Kwon","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0080","doi-asserted-by":"crossref","first-page":"21933","DOI":"10.1038\/srep21933","article-title":"Engineering hybrid exosomes by membrane fusion with liposomes","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2023.213388_bb0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.omtn.2021.04.018","article-title":"Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis","volume":"24","author":"Kim","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bioadv.2023.213388_bb0090","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.addr.2021.03.020","article-title":"Approaches to surface engineering of extracellular vesicles","volume":"173","author":"Richter","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"13","key":"10.1016\/j.bioadv.2023.213388_bb0095","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1074\/jbc.M114.621383","article-title":"Stabilization of exosome-targeting peptides via engineered Glycosylation*","volume":"290","author":"Hung","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioadv.2023.213388_bb0100","article-title":"Advances in extracellular vesicle functionalization strategies for tissue regeneration","author":"Zheng","year":"2022","journal-title":"Bioact Mater."},{"key":"10.1016\/j.bioadv.2023.213388_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119475","article-title":"Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance","volume":"223","author":"Liu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2023.213388_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","article-title":"PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time","volume":"224","author":"Kooijmans","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.bioadv.2023.213388_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2021.06.031","article-title":"Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo","volume":"336","author":"You","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12951-021-01180-0","article-title":"Combined integrin \u03b1(v)\u03b2(3) and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect","volume":"19","author":"Qi","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2023.213388_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111673","article-title":"Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy","volume":"202","author":"Gong","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"22","key":"10.1016\/j.bioadv.2023.213388_bb0130","doi-asserted-by":"crossref","first-page":"36614","DOI":"10.18632\/oncotarget.16625","article-title":"Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: an in vitro boron neutron capture therapy study","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioadv.2023.213388_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122152","article-title":"The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier","volume":"626","author":"Reginald-Opara","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jim.2008.03.001","article-title":"Increased exosome production from tumour cell cultures using the integra CELLine culture system","volume":"335","author":"Mitchell","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioadv.2023.213388_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111527","article-title":"Protein corona components of polyethylene glycol-conjugated organosilica nanoparticles modulates macrophage uptake","volume":"199","author":"Kim","year":"2021","journal-title":"Colloids Surf B Biointerfaces."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213388_bb0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","article-title":"Macrophage-derived extracellular vesicles as drug delivery Systems for Triple Negative Breast Cancer (TNBC) therapy","volume":"15","author":"Haney","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.bioadv.2023.213388_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.bioadv.2023.213388_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"15","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"issue":"15","key":"10.1016\/j.bioadv.2023.213388_bb0165","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2217\/nnm-2018-0510","article-title":"Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery","volume":"14","author":"Kanamala","year":"2019","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.bioadv.2023.213388_bb0170","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fimmu.2018.00738","article-title":"Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression","volume":"9","author":"Willms","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2023.213388_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122153","article-title":"A simple approach to re-engineering small extracellular vesicles to circumvent endosome entrapment","volume":"626","author":"Geng","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2023.213388_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejpb.2019.10.005","article-title":"Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues","volume":"145","author":"Emam","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213388_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213388_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1014434732752","article-title":"Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity","volume":"19","author":"Moreira","year":"2002","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.bioadv.2023.213388_bb0195","doi-asserted-by":"crossref","first-page":"1801807","DOI":"10.1002\/admi.201801807","article-title":"PEG-lipid post insertion into drug delivery liposomes quantified at the single liposome level","volume":"6","author":"Eliasen","year":"2019","journal-title":"Adv. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2021.2003656","article-title":"Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo","volume":"23","author":"Patras","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213388_bb0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11095-018-2429-y","article-title":"PEG-benzaldehyde-hydrazone-lipid based PEG-sheddable pH-sensitive liposomes: abilities for endosomal escape and long circulation","volume":"35","author":"Kanamala","year":"2018","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213388_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122419","article-title":"Adsorption of cationic peptides to solid surfaces of glass and plastic","volume":"10","author":"Kristensen","year":"2015","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijpharm.2016.01.068","article-title":"Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration","volume":"501","author":"Li","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2023.213388_bb0220","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jconrel.2015.10.039","article-title":"Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region","volume":"220","author":"Amin","year":"2015","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.bioadv.2023.213388_bb0225","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s11095-016-1902-8","article-title":"Development of long-circulating pH-sensitive liposomes to circumvent gemcitabine resistance in pancreatic cancer cells","volume":"33","author":"Xu","year":"2016","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"24","key":"10.1016\/j.bioadv.2023.213388_bb0235","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/S0142-9612(03)00343-0","article-title":"RGD modified polymers: biomaterials for stimulated cell adhesion and beyond","volume":"24","author":"Hersel","year":"2003","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s42003-021-02965-7","article-title":"Real time imaging of single extracellular vesicle pH regulation in a microfluidic cross-flow filtration platform","volume":"5","author":"Riazanski","year":"2022","journal-title":"Commun Biol."},{"issue":"10","key":"10.1016\/j.bioadv.2023.213388_bb0245","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11095-014-1353-z","article-title":"Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells","volume":"31","author":"Xu","year":"2014","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12951-019-0517-8","article-title":"Exosome-mimetic nanoplatforms for targeted cancer drug delivery","volume":"17","author":"V\u00e1zquez-R\u00edos","year":"2019","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.bioadv.2023.213388_bb0255","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.actbio.2019.05.054","article-title":"Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery","volume":"94","author":"Rayamajhi","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2023.213388_bb0260","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.2147\/IJN.S218988","article-title":"A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro","volume":"14","author":"Wei","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213388_bb0265","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/IJN.S125573","article-title":"Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects","volume":"12","author":"Song","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.bioadv.2023.213388_bb0270","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1039\/C6NR00247A","article-title":"Doxorubicin conjugated functionalizable carbon dots for nucleus targeted delivery and enhanced therapeutic efficacy","volume":"8","author":"Yang","year":"2016","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0275","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/s41467-021-22126-y","article-title":"Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells","volume":"12","author":"Bonsergent","year":"2021","journal-title":"Nat. Commun."},{"issue":"40","key":"10.1016\/j.bioadv.2023.213388_bb0280","doi-asserted-by":"crossref","first-page":"66889","DOI":"10.18632\/oncotarget.17976","article-title":"Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment","volume":"8","author":"Belhadj","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioadv.2023.213388_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121691","article-title":"pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin","volume":"619","author":"Garc\u00eda","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1515\/chem-2022-0122","article-title":"Anti-tumor effect of liposomes containing extracted murrayafoline a against liver cancer cells in 2D and 3D cultured models","volume":"20","author":"Pham","year":"2022","journal-title":"Open Chem."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213388_bb0295","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/ncomms2282","article-title":"Delivery of chemotherapeutic drugs in tumour cell-derived microparticles","volume":"3","author":"Tang","year":"2012","journal-title":"Nat. Commun."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:49:12Z","timestamp":1757425752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950823001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"alternative-id":["S2772950823001115"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213388","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213388"}}